# Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

> **NCT00234910** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 152 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Tenofovir DF
- **DRUG:** lopinavir/ritonavir with 2 Nucleoside RTIs

## Key facts

- **NCT ID:** NCT00234910
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-06
- **Final completion:** 2008-06
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2008-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234910, "Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00234910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*